Unimed's dihydrotestosterone gel product Androgel is an effective treatment for AIDS wasting syndrome, according to researchers from Beth Israel Hospital in Boston, USA. Daily application of the gel resulted in improved appetite, significant weight gain, increased lean body mass, improved mobility, more stamina and less depression. Prior attempts to treat AIDS wasting with testosterone have been disappointing, probably because AIDS sufferers have a lower than normal ability to convert testosterone to dihydrotestosterone, which is thought to trigger the beneficial effects.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze